Answers are grounded in this paper and cite their sources.
Analysis reveals access disparities in GLP-1 receptor agonists in Brazil, suggesting regulatory improvements are needed.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Hurtado et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: